Skip to main content
. 2020 Mar 25;35(1):840–846. doi: 10.1080/14756366.2020.1743988

Figure 6.

Figure 6.

Differential inhibition of AKR1B1 by synthetic and natural compounds. The bars refer to the differential inhibition between aldoses reduction and HNE reduction. The letters along the bars refer to: a: D-glyceramide15; b: D-gluconamide15; c: pyrazol[1,5-a]pyrimidine derivative (compound 5e52); d: soyasaponin55; e: NHDC20; f: sorbinil52; g: epalrestat52; h: [1,2,4]oxadiazol-5-yl-acetic acid derivative (compound 915); i: Saccharin derivative (compound 1615).